Rash in systemic lupus erythematosus: Prevalence and relation to cutaneous and non-cutaneous disease manifestations

Arjeh J. Wysenbeek, Daniele Guedj, Mirit Amit, Abraham Weinberger

Research output: Contribution to journalArticlepeer-review

Abstract

Rash is a common cutaneous sign in patients with systemic lupus erythematosus (SLE) but no data regarding its prevalence or relation to disease manifestations are known, possibly due to the fact that it is a common but nonspecific sign. Rash was present in 48/81 (59%) patients with SLE. Patients with rash had more cutaneous symptoms and signs, lymphadenopathy, increased levels of antibodies to double stranded DNA and decreased complement levels. They were also receiving a higher dose of prednisone. There was no difference between patients with and without rash with respect to renal or central nervous system disease. Rash did not correlate with the disease activity index and clinical parameters of disease exacerbation.

Original languageEnglish
Pages (from-to)717-719
Number of pages3
JournalAnnals of the Rheumatic Diseases
Volume51
Issue number6
DOIs
StatePublished - 1992

Fingerprint

Dive into the research topics of 'Rash in systemic lupus erythematosus: Prevalence and relation to cutaneous and non-cutaneous disease manifestations'. Together they form a unique fingerprint.

Cite this